Hematology. 2005 Feb;10(1):39-46.

CD38 as a prognostic marker in CLL.

Source

Department of Clinical Haematology, national Medical Center, Budapest, Hungary. matraiz@hotmail.com

Abstract

Cell-surface expression of CD38 in CLL has been recognised recently as a marker of progressive disease and poor outcome. In contrast to traditional staging systems, CD38 is able to identify progressive cases at an early stage. Measurement of CD38, in conjunction with other novel prognostic factors such as p53 and ZAP-70 helps to identify patients who might benefit from early and more intensive therapy. In addition, CD38 positivity can predict unmutated IgVH gene mutation status in most cases. These features, together with its easy applicability, render CD38 a valuable tool in the routine diagnostics of CLL. Questions remaining to be clarified about CD38 include the incidence and significance of its variations during the course of the disease, the optimal method to define CD38 positivity and the impact of different methodologies on results. Only after these issues are resolved can the definitive place of CD38 be defined in the diagnostics of CLL.

PMID:: 16019444; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Supplemental Content

Save items

Related citations in PubMed

ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. [Blood. 2003]
ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.
Wiestner A, Rosenwald A, Barry TS, Wright G, Davis RE, Henrickson SE, Zhao H, Ibbotson RE, Orchard JA, Davis Z, et al. Blood. 2003 Jun 15; 101(12):4944-51. Epub 2003 Feb 20.
Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia. [Leukemia. 2005]
Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
Schroers R, Griesinger F, Trümper L, Haase D, Kulle B, Klein-Hitpass L, Sellmann L, Dührsen U, Dürig J. Leukemia. 2005 May; 19(5):750-8.
ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. [N Engl J Med. 2003]
ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.
Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M, Marcé S, López-Guillermo A, Campo E, Montserrat E. N Engl J Med. 2003 May 1; 348(18):1764-75.
Review The prognostic value of CD38 expression and its quantification in B cell chronic lymphocytic leukemia (B-CLL). [Leuk Lymphoma. 2004]
Review The prognostic value of CD38 expression and its quantification in B cell chronic lymphocytic leukemia (B-CLL).
Mainou-Fowler T, Dignum HM, Proctor SJ, Summerfield GP. Leuk Lymphoma. 2004 Mar; 45(3):455-62.
Review The use of CD38 expression by monoclonal B lymphocytes as a prognostic factor in B-cell chronic lymphocytic leukemia. [J Biol Regul Homeost Agents. 2...]
Review The use of CD38 expression by monoclonal B lymphocytes as a prognostic factor in B-cell chronic lymphocytic leukemia.
Boonstra JG, von't Veer MB, Gratama JW. J Biol Regul Homeost Agents. 2004 Jul-Dec; 18(3-4):340-6.

See reviews... See all...

Cited by 5 PubMed Central articles

CD38/CD31 interactions activate genetic pathways leading to proliferation and migration in chronic lymphocytic leukemia cells. [Mol Med. 2010]
CD38/CD31 interactions activate genetic pathways leading to proliferation and migration in chronic lymphocytic leukemia cells.
Deaglio S, Aydin S, Grand MM, Vaisitti T, Bergui L, D'Arena G, Chiorino G, Malavasi F. Mol Med. 2010 Mar; 16(3-4):87-91. Epub 2009 Nov 20.
Review Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance. [J Transl Med. 2009]
Review Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance.
Dal-Bo M, Bertoni F, Forconi F, Zucchetto A, Bomben R, Marasca R, Deaglio S, Laurenti L, Efremov DG, Gaidano G, et al. J Transl Med. 2009 Aug 28; 7:76. Epub 2009 Aug 28.
Mechanism-based small molecule probes for labeling CD38 on live cells. [J Am Chem Soc. 2009]
Mechanism-based small molecule probes for labeling CD38 on live cells.
Jiang H, Congleton J, Liu Q, Merchant P, Malavasi F, Lee HC, Hao Q, Yen A, Lin H. J Am Chem Soc. 2009 Feb 11; 131(5):1658-9.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

CD38 as a prognostic marker in CLL.
CD38 as a prognostic marker in CLL.
Hematology. 2005 Feb ;10(1):39-46.

PubMed
Depressive disorders in caregivers of dementia patients: a systematic review.
Depressive disorders in caregivers of dementia patients: a systematic review.
Aging Ment Health. 2005 Jul ;9(4):325-30.

PubMed
Judging female figures: a new methodological approach to male attractiveness jud...
Judging female figures: a new methodological approach to male attractiveness judgments of female waist-to-hip ratio.
Biol Psychol. 2006 Feb ;71(2):223-9. Epub 2005 Jul 12 .

PubMed
Getting rid of caveolins: phenotypes of caveolin-deficient animals.
Getting rid of caveolins: phenotypes of caveolin-deficient animals.
Biochim Biophys Acta. 2005 Dec 30 ;1746(3):322-33. Epub 2005 Jun 23 .

PubMed
Poison control centers in developing countries and Asia's need for toxicology ed...
Poison control centers in developing countries and Asia's need for toxicology education.
Toxicol Appl Pharmacol. 2005 Sep 1 ;207(2 Suppl):716-21.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

CD38 as a prognostic marker in CLL.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Supplemental Content

Save items

Related citations in PubMed

Cited by 5 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information